Healthcare provider profile · identity verified

David Verle Schrodt, MD

General Practice · CHARLES CITY, IA · NPI 1710979992

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	498	126
Metoprolol Succinate	Metoprolol Succinate	481	117
Levothyroxine Sodium	Levothyroxine Sodium	373	77
Tramadol Hcl	Tramadol Hcl	329	73
Lisinopril	Lisinopril	316	78
Amlodipine Besylate	Amlodipine Besylate	302	83
Furosemide	Furosemide	244	57
Eliquis	Apixaban	243	40
Omeprazole	Omeprazole	214	57
Warfarin Sodium	Warfarin Sodium	210	34
Simvastatin	Simvastatin	208	44
Allopurinol	Allopurinol	194	44
Tamsulosin Hcl	Tamsulosin Hcl	185	51
Losartan Potassium	Losartan Potassium	175	51
Pantoprazole Sodium	Pantoprazole Sodium	162	47
Carvedilol	Carvedilol	160	35
Potassium Chloride	Potassium Chloride	159	33
Escitalopram Oxalate	Escitalopram Oxalate	152	35
Torsemide	Torsemide	151	29
Famotidine	Famotidine	143	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	142	38
Metoprolol Tartrate	Metoprolol Tartrate	141	33
Trazodone Hcl	Trazodone Hcl	134	34
Metformin Hcl	Metformin Hcl	132	35
Alprazolam	Alprazolam	125	27
Olmesartan Medoxomil	Olmesartan Medoxomil	121	37
Rosuvastatin Calcium	Rosuvastatin Calcium	118	31
Ozempic	Semaglutide	117	20
Quetiapine Fumarate	Quetiapine Fumarate	116	21
Sertraline Hcl	Sertraline Hcl	116	24
Gabapentin	Gabapentin	110	26
Albuterol Sulfate Hfa	Albuterol Sulfate	102	31
Lorazepam	Lorazepam	102	16
Jardiance	Empagliflozin	97	14
Citalopram Hbr	Citalopram Hydrobromide	88	26
Hydrochlorothiazide	Hydrochlorothiazide	86	25
Glipizide	Glipizide	82	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	81	15
Prednisone	Prednisone	79	38
Finasteride	Finasteride	76	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	75	14
Montelukast Sodium	Montelukast Sodium	72	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	70	21
Clopidogrel	Clopidogrel Bisulfate	69	21
Mirtazapine	Mirtazapine	68	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	13
Trulicity	Dulaglutide	65	suppressed
Xarelto	Rivaroxaban	62	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	61	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	60	13
Buspirone Hcl	Buspirone Hcl	59	11
Fluoxetine Hcl	Fluoxetine Hcl	58	18
Levofloxacin	Levofloxacin	53	46
Nifedipine Er	Nifedipine	53	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	52	16
Cephalexin	Cephalexin	51	31
Doxycycline Monohydrate	Doxycycline Monohydrate	51	42
Donepezil Hcl	Donepezil Hcl	49	suppressed
Farxiga	Dapagliflozin Propanediol	47	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Pregabalin	Pregabalin	44	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Clonazepam	Clonazepam	39	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	11
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	12
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	17
Ezetimibe	Ezetimibe	29	suppressed
Glipizide Er	Glipizide	29	11
Spironolactone	Spironolactone	29	suppressed
Methylprednisolone	Methylprednisolone	28	24
Dexlansoprazole Dr	Dexlansoprazole	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	16
Atenolol	Atenolol	24	suppressed
Baclofen	Baclofen	24	11
Dutasteride	Dutasteride	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Risperidone	Risperidone	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Humalog	Insulin Lispro	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Azithromycin	Azithromycin	19	18
Fenofibrate	Fenofibrate	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Temazepam	Temazepam	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Metronidazole	Metronidazole	17	11
Timolol Maleate	Timolol Maleate	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Metolazone	Metolazone	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Haloperidol	Haloperidol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Dexilant	Dexlansoprazole	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Primidone	Primidone	11	suppressed
Ramipril	Ramipril	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error